Answer
Yes. The licensed information permits switching at a planned treatment visit, but the products are not directly interchangeable during preparation because their routes and handling differ.
Sources for this answer
- KEYTRUDA 25 mg/mL concentrate for solution for infusion — Current selected SmPCemc · Summary of Product Characteristics
- KEYTRUDA 395 mg solution for injection — Current selected SmPCemc · Summary of Product Characteristics